Prosecution Insights
Last updated: July 17, 2026
Application No. 18/676,975

RF THERAPEUTIC DEVICE AND METHOD FOR CONTROLLING SAME

Non-Final OA §112
Filed
May 29, 2024
Priority
Dec 31, 2018 — RE 10-2018-0173464 +2 more
Examiner
KAHELIN, MICHAEL WILLIAM
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Lutronic Corporation
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
522 granted / 671 resolved
+7.8% vs TC avg
Strong +24% interview lift
Without
With
+24.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
34 currently pending
Career history
701
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
69.0%
+29.0% vs TC avg
§102
8.2%
-31.8% vs TC avg
§112
9.8%
-30.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 671 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of claims 1-12 in the reply filed on 5/22/2026 is acknowledged. Claim Objections Claim 10 is objected to because of the following informalities: in line 5, “parameters to at a subsequent insertion position” should read --parameters to a subsequent insertion position--. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In regards to claim 1, the phrase “led by processing error occurred in a manufacturing process” is vague. The scope of “led by” is vague because it is unclear how a “processing error” can “lead” anything, and this appears to be a translation error from the parent application. For purposes of considering prior art, the examiner is considering the claim to have a meaning of “caused by a processing error of the insert that occurred in a manufacturing process,” and such language would obviate this rejection. The remaining claims are rejected by virtue of their dependency. Allowable Subject Matter Claims 1-12 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: the closest prior art is to Berube (US 2010/0262135). Although Berube generally discloses an RF therapy device with an RF generator, an insert with an RF electrode, and sensor for measuring impedance while the RF energy is being transferred to body tissue (Fig. 2A; pars. 0040, 0153, 0162, 0190), Berube does not, alone or in combination with the remaining prior art, disclose or fairly render unpatentable the combination of elements including an identifier to identify information about an electrical characteristic of the RF electrode caused by a processing error of the insert that occurred in a manufacturing process. As set forth in Applicant’s disclosure, this is intended to account for the varying impedances of very small needle electrodes that can arise due to manufacturing defects (par. 51). The prior art does not disclose an identifier to identify information about an electrical characteristic of the RF needle electrode in such a situation. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL W KAHELIN whose telephone number is (571)272-8688. The examiner can normally be reached M-F, 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached at (571)270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL W KAHELIN/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

May 29, 2024
Application Filed
Jun 10, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678254
DRAPE MANAGEMENT SYSTEM
2y 1m to grant Granted Jul 14, 2026
Patent 12667721
BEAUTY INSTRUMENT
2y 7m to grant Granted Jun 30, 2026
Patent 12661266
SINGLE AND/OR DUAL (532 AND/OR 577) nm LASER DELIVERY SYSTEM ATTACHED TO AN OPHTHALMIC MICROSCOPE
2y 4m to grant Granted Jun 23, 2026
Patent 12642474
COMPUTATIONAL METHOD FOR LOCALIZING THE ORIGIN OF ARRHYTHMIA
2y 4m to grant Granted Jun 02, 2026
Patent 12635937
Coherence-Based Method, Apparatus, and System for Identifying Corresponding Signals of a Physiological Study
2y 5m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+24.0%)
3y 2m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 671 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month